Frailty in outpatients with cirrhosis: A prospective observational study.

Eva Román, Marc Parramón, Montserrat Flavià, Cristina Gely, Maria Poca, Adolfo Gallego, Rosalia Santesmases, Elvira Hernández, Juan C Nieto, Eulàlia Urgell, Edilmar Alvarado-Tapias, Silvia Vidal, Andreu Ferrero-Gregori, Víctor Vargas, Carlos Guarner, German Soriano

Journal: Liver international : official journal of the International Association for the Study of the Liver 2021;41(2):357-368

PMID: 33030788

Abstract

BACKGROUND AND AIM

Frailty is increasingly recognized as a major prognostic factor in cirrhosis in addition to conventional liver insufficiency scores. The aim was to compare the prevalence and characteristics of frailty between patients with cirrhosis and controls, and to analyse its prognostic value.

METHODS

We included outpatients with cirrhosis and age- and gender-matched non-cirrhotic controls. Frailty was defined according to the Fried frailty criteria. In patients with cirrhosis, we analysed the ability of the degree of frailty to predict a composite endpoint, consisting of hospitalization, admission to a long-term care centre, falls or death.

RESULTS

We included 135 patients with cirrhosis and 135 controls. The prevalence of frailty was higher among patients with cirrhosis: 35 (25.9%) frail, 74 (54.8%) pre-frail and 26 (19.2%) robust vs 14 (10.4%) frail, 67 (49.6%) pre-frail and 54 (40%) robust (P < .001) in controls. This difference was mainly as a result of decreased muscle strength in patients with cirrhosis. During follow-up, frail patients with cirrhosis showed a higher probability of composite endpoint, hospitalization and falls than pre-frail and robust cirrhotic patients but mortality was similar. MELD-Na score and frailty were independent predictive factors for hospitalization, frailty for falls, and MELD-Na score and albumin for survival. Vitamin D deficiency and increased cystatin C were associated with frailty.

CONCLUSIONS

Frailty was more frequent in outpatients with cirrhosis than in controls, mainly because of a decrease in muscle strength, and it could be a predictive factor for hospitalization and falls in these patients.

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Address: Escola Universitària d'Infermeria EUI-Sant Pau, Barcelona, Spain.; Department of Gastroenterology at Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain.; Primary Care Center Passeig Maragall, Barcelona, Spain.; Liver Unit, Hospital Vall d'Hebron, Barcelona, Spain.; Research Institute IIB-Sant Pau, Barcelona, Spain.; Department of Biochemistry, Barcelona, Spain.; Department of Immunology at Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; INCLIVA Health Research Institute, Valencia, Spain.; Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO), Valencia, Spain.; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.